104 related articles for article (PubMed ID: 38675678)
1. A fast, open source implementation of adaptive biasing potentials uncovers a ligand design strategy for the chromatin regulator BRD4.
Dickson BM; de Waal PW; Ramjan ZH; Xu HE; Rothbart SB
J Chem Phys; 2016 Oct; 145(15):154113. PubMed ID: 27782467
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanism of Phosphorylation-Mediated Impacts on the Conformation Dynamics of GTP-Bound KRAS Probed by GaMD Trajectory-Based Deep Learning.
Chen J; Wang J; Yang W; Zhao L; Zhao J; Hu G
Molecules; 2024 May; 29(10):. PubMed ID: 38792177
[TBL] [Abstract][Full Text] [Related]
3. An Overview on Small Molecule Inhibitors of BRD4.
Huang W; Zheng X; Yang Y; Wang X; Shen Z
Mini Rev Med Chem; 2016; 16(17):1403-1414. PubMed ID: 27290915
[TBL] [Abstract][Full Text] [Related]
4. Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning.
Wang J; Yang W; Zhao L; Wei B; Chen J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675678
[TBL] [Abstract][Full Text] [Related]
5. Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations.
Su J; Liu X; Zhang S; Yan F; Zhang Q; Chen J
Chem Biol Drug Des; 2019 Feb; 93(2):163-176. PubMed ID: 30225973
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations.
Song LT; Tu J; Liu RR; Zhu M; Meng YJ; Zhai HL
J Biomol Struct Dyn; 2019 Jul; 37(11):2970-2979. PubMed ID: 30058436
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel BRD4-BD2 inhibitors via in silico approaches: QSAR techniques, molecular docking, and molecular dynamics simulations.
Tong JB; Xiao XC; Luo D; Xu HY; Xing YC; Gao P; Liu Y
Mol Divers; 2024 Apr; 28(2):671-692. PubMed ID: 36773087
[TBL] [Abstract][Full Text] [Related]
9. In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4.
RodrÃguez Y; Gerona-Navarro G; Osman R; Zhou MM
Proteins; 2020 Mar; 88(3):414-430. PubMed ID: 31587361
[TBL] [Abstract][Full Text] [Related]
10. Roles of Accelerated Molecular Dynamics Simulations in Predictions of Binding Kinetic Parameters.
Chen J; Wang W; Sun H; He W
Mini Rev Med Chem; 2024 Jan; ():. PubMed ID: 38265367
[TBL] [Abstract][Full Text] [Related]
11. Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors.
Do HN; Wang J; Miao Y
JACS Au; 2023 Nov; 3(11):3165-3180. PubMed ID: 38034960
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights and optimization strategies for the competitive binding of engineered ACE2 proteins: a multiple replica molecular dynamics study.
Sun J; Liu X; Zhang S; Li M; Zhang Q; Chen J
Phys Chem Chem Phys; 2023 Oct; 25(41):28479-28496. PubMed ID: 37846774
[TBL] [Abstract][Full Text] [Related]
13. The Power of Molecular Dynamics Simulations and Their Applications to Discover Cysteine Protease Inhibitors.
Dos Santos Nascimento IJ; Santana Gomes JN; de Oliveira Viana J; de Medeiros E Silva YMS; Barbosa EG; de Moura RO
Mini Rev Med Chem; 2023 Sep; ():. PubMed ID: 37680157
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]